You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR CAYSTON

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for CAYSTON

Subscribe to access the full database, or Subscribe
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01746095 ↗	Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients	Completed	Cystic Fibrosis Foundation	Phase 2	2013-03-01	The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT01746095 ↗	Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients	Completed	Cystic Fibrosis Foundation Therapeutics	Phase 2	2013-03-01	The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
NCT01746095 ↗	Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients	Completed	Synteract, Inc.	Phase 2	2013-03-01	The purpose of this study is to determine whether AeroVanc treatment is safe and effective in reducing the number of MRSA colony forming units in the lungs of cystic fibrosis patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for CAYSTON

Condition Name

Chart
Table

Condition Name for CAYSTON
Intervention	Trials
Cystic Fibrosis	3
Infection	1
Pseudomonas	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for CAYSTON
Intervention	Trials
Fibrosis	4
Cystic Fibrosis	4
Pseudomonas Infections	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for CAYSTON

Trials by Country

Map
Table

Trials by Country for CAYSTON
Location	Trials
United States	56
United Kingdom	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for CAYSTON
Location	Trials
California	3
Washington	2
Utah	2
Texas	2
Tennessee	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for CAYSTON

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for CAYSTON
Clinical Trial Phase	Trials
Phase 4	2
Phase 2	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for CAYSTON
Clinical Trial Phase	Trials
Active, not recruiting	2
Completed	2
Terminated	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for CAYSTON

Sponsor Name

Chart
Table

Sponsor Name for CAYSTON
Sponsor	Trials
Gilead Sciences	2
Cystic Fibrosis Foundation	2
Cystic Fibrosis Foundation Therapeutics	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for CAYSTON
Sponsor	Trials
Other	11
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.